A peculiar place for a feminist? The New South African woman, True Love magazine and Lebo(gang) Mashile
Safundi · 02.04.2016 · 17 (2) · 119-136
DOI: 10.1080/17533171.2016.1178470 ↗Kurz gefasst
Fachartikel in der Zeitschrift Safundi, online erschienen am 03.06.2016. Verfasst von Pumla Dineo Gqola. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 44 Literaturangaben.
Abstract (Originalsprache)
Among the least studied aspects of post-apartheid South African public culture is the emergence of the trope of the New South African woman (NSAW). As a feature of public life that receives high circulation in the first two decades of South Africa’s democracy, the NSAW works aspirationally and normatively. In this essay, I am concerned with one feminist artist’s varied engagements with the NSAW. I analyze Lebogang Mashile’s column in and fallout with True Love magazine and delineate features of the NSAW trope, a construction of femininity at once aspirational and restrictive. Throughout this essay, although I draw on the literature on “new women” from other societies in transition, the “new” in NSAW refers to one of a range of highly circulated aspirational subjectivities in post-apartheid South Africa. Consequently, the “new” in the NSAW trope refers to the labeling of commonplace usage of “new South Africa” for South African society after 1994.
Zitieren
APA
Gqola, P. D. (2016). A peculiar place for a feminist? The New South African woman, True Love magazine and Lebo(gang) Mashile. Safundi, 17(2), 119-136. https://doi.org/10.1080/17533171.2016.1178470
Vancouver
Gqola PD. A peculiar place for a feminist? The New South African woman, True Love magazine and Lebo(gang) Mashile. Safundi. 2016;17(2):119-136. doi:10.1080/17533171.2016.1178470
BibTeX
@article{Gqola2016,
author = {Gqola, Pumla Dineo},
title = {A peculiar place for a feminist? The New South African woman, True Love magazine and Lebo(gang) Mashile},
journal = {Safundi},
year = {2016},
volume = {17},
number = {2},
pages = {119--136},
doi = {10.1080/17533171.2016.1178470}
}
EUVIMED